efavirenz has been researched along with bms 433771 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
| Boido, V; Collu, G; Delogu, I; Giliberti, G; La Colla, P; Loddo, R; Novelli, F; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M | 1 |
2 other study(ies) available for efavirenz and bms 433771
| Article | Year |
|---|---|
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cricetinae; DNA Viruses; Dogs; Enterovirus B, Human; Humans; RNA Viruses; Structure-Activity Relationship; Triazoles; Virus Replication | 2015 |